Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation

BACKGROUND: Bitter melon (BM, Momordica charantia) has been accepted as an effective complementary treatment of metabolic disorders such as diabetes, hypertension, dyslipidemia and etc. However it is unclear whether BM can prevent the progression of atherosclerosis. To confirm the effects of BM on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yanmei, Guan, Meiping, Li, Chenzhong, Xu, Lingling, Zheng, Zhongji, Li, Jimin, Xue, Yaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220495/
https://www.ncbi.nlm.nih.gov/pubmed/30400958
http://dx.doi.org/10.1186/s12944-018-0896-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220495/
https://www.ncbi.nlm.nih.gov/pubmed/30400958
http://dx.doi.org/10.1186/s12944-018-0896-0

Ejemplares similares